{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:16:21Z","timestamp":1759342581564,"version":"3.44.0"},"reference-count":10,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,10,26]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Glucocorticoid excess is an under-recognised cause of cardiovascular adverse effects. The sources can be either endogenous (Cushing\u2019s syndrome) or exogenous (Anabolic steroid abuse). Cardiovascular complications due to excess glucocorticoid includes hypertension, left ventricular hypertrophy, myocardial infarction, and heart failure. Although anabolic steroid-induced cardiomyopathy is a well-recognised phenomenon, endogenous corticosteroid-induced cardiomyopathy and heart failure are rarely reported sequelae of glucocorticoid excess in the body. We report a glucocorticoid-induced dilated cardiomyopathy in a 26-year-old African\u2013American man with cushingoid features and symptomatic heart failure.<\/jats:p>","DOI":"10.1136\/bcr-2020-237173","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T16:36:01Z","timestamp":1604939761000},"page":"e237173","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Glucocorticoid-induced cardiomyopathy: unexpected conclusion"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8519-2747","authenticated-orcid":false,"given":"Taha","family":"Sheikh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Toledo, Toledo, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hina","family":"Shuja","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Karachi Medical and Dental College, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-3302","authenticated-orcid":false,"given":"Syeda Ramsha","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, St Joseph Mercy Health System, Livonia, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayema","family":"Haque","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"2025082723453949000_13.11.e237173.1","doi-asserted-by":"crossref","unstructured":"Delivanis DA . Chapter 15 - Advances in the Diagnosis and Medical Management of Cushing\u2019s Syndrome. Advances in Treatment and Management in Surgical Endocrinology 2020:151\u201374.","DOI":"10.1016\/B978-0-323-66195-9.00015-7"},{"key":"2025082723453949000_13.11.e237173.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.004569"},{"key":"2025082723453949000_13.11.e237173.3","doi-asserted-by":"crossref","unstructured":"B\u0130 A , Gerede DM , Canpolat AG , et al . Cushing\u2019s Disease Presented by Reversible Dilated Cardiomyopathy. Case Rep Cardiol 2015;2015.","DOI":"10.1155\/2015\/980897"},{"key":"2025082723453949000_13.11.e237173.4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2169\/internalmedicine.52.9051","article-title":"Dilated cardiomyopathy as a presenting feature of Cushing's syndrome","volume":"52","author":"Shibusawa","year":"2013","journal-title":"Intern Med"},{"key":"2025082723453949000_13.11.e237173.5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002011","article-title":"Dilated cardiomyopathy revealing Cushing disease: a case report and literature review","volume":"94","author":"Marchand","year":"2015","journal-title":"Medicine"},{"key":"2025082723453949000_13.11.e237173.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2009.00123.x"},{"key":"2025082723453949000_13.11.e237173.7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.12.2010.3650"},{"key":"2025082723453949000_13.11.e237173.8","doi-asserted-by":"crossref","unstructured":"Gill A , Dean N , Cushing\u2019s A-AR . Dilated cardiomyopathy and stroke: case report and literature review. Can J Gen Intern Med 2016;11.","DOI":"10.22374\/cjgim.v11i2.139"},{"key":"2025082723453949000_13.11.e237173.9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_125_17","article-title":"Adrenocortical carcinoma presenting as reversible dilated cardiomyopathy","volume":"19","author":"Abdulla","year":"2018","journal-title":"Heart Views"},{"key":"2025082723453949000_13.11.e237173.10","doi-asserted-by":"crossref","first-page":"MON","DOI":"10.1210\/js.2019-MON-404","article-title":"MON-404 Reversible Dilated Cardiomyopathy in a Severe Case of Cushing\u2019s Disease","volume":"3","author":"Valente do Couto","year":"2019","journal-title":"J Endocr Soc"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-237173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:45:50Z","timestamp":1756363550000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-237173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":10,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,9]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/bcr-2020-237173"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-237173","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}